Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
venBio Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
venBio Partners

venBio Partners

Operating

venBio: A leading life sciences investment firm, funding promising startups to late-stage ventures.

Location
San Francisco, CA, US
Founded
2009
Firm
Compare
Portfolio
Employees
Website

venBio Partners is a leading life sciences investment firm that funds companies across various stages, from early to late-stage ventures. Their investment strategy includes leading most of their investments and building syndicates and teams. venBio's typical investment rounds include Series A, B, C, D, and E, with a strong focus on companies that have potential for significant impact in the life sciences sector.

Notable portfolio companies include Apellis Pharmaceuticals, Fog Pharmaceuticals, Harmony Biosciences, and Precision BioSciences. venBio's team brings extensive expertise in intellectual property, chemistry, manufacturing, clinical trial design, and regulatory considerations to help their portfolio companies succeed. Their investment philosophy emphasizes positioning companies for potential acquisition from the outset, ensuring they meet the rigorous requirements of potential acquirers.

venBio Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments32
Current Portfolio Count23
Total Portfolio Exits0

Top Investment Stages

Series A13 (43.3%)
Series B7 (23.3%)
Series C4 (13.3%)
Series D3 (10.0%)
Series Unknown3 (10.0%)

Stage Mix

Series A 43%Series B 23%Series C 13%Series D 10%Series Unknown 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Attovia Therapeutics logo

Attovia Therapeutics

Entact Bio logo

Entact Bio

Fog Pharmaceuticals logo

Fog Pharmaceuticals

Immpact Bio logo

Immpact Bio

Ceptur Therapeutics logo

Ceptur Therapeutics

HistoWiz logo

HistoWiz

Inbrace logo

Inbrace

Attralus logo

Attralus

Neurogastrx logo

Neurogastrx

Artiva Biotherapeutics logo

Artiva Biotherapeutics

Tallac Therapeutics logo

Tallac Therapeutics

Stargazer Pharmaceuticals logo

Stargazer Pharmaceuticals

NFlection Therapeutics logo

NFlection Therapeutics

Aeovian Pharmaceuticals logo

Aeovian Pharmaceuticals

Arrakis Therapeutics logo

Arrakis Therapeutics

Precision BioSciences logo

Precision BioSciences

Harmony Biosciences logo

Harmony Biosciences

Apellis Pharmaceuticals logo

Apellis Pharmaceuticals

Vyne Therapeutics logo

Vyne Therapeutics

Outlook Therapeutics logo

Outlook Therapeutics

Cidara Therapeutics logo

Cidara Therapeutics

Bellicum Pharmaceuticals logo

Bellicum Pharmaceuticals

Solstice Biologics logo

Solstice Biologics

venBio Partners - Similar Investment Firms

Bioventures Investors logo

Bioventures Investors

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Avoro Capital Advisors logo

Avoro Capital Advisors

avorocapital.com

Nan Fung Life Sciences logo

Nan Fung Life Sciences

Biospring Partners logo

Biospring Partners

biospring.com

Bios Partners logo

Bios Partners

biospartners.com

Venn Ventures logo

Venn Ventures

vennventures.com

Vesper Ventures logo

Vesper Ventures

vesper-bio.com

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

Westlake Village BioPartners logo

Westlake Village BioPartners

westlakebio.com

V-Bio Ventures logo

V-Bio Ventures

v-bio.ventures

Healthcare Ventures logo

Healthcare Ventures

hcven.com

BioInnovation logo

BioInnovation

Alpine BioVentures GP logo

Alpine BioVentures GP

venBio Partners - Classification

Also Known As
  • venBio Partners L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end